Recent News

• 11.21.2025 - Chairman’s Address 2025 Annual General Meeting
• 11.21.2025 - AGM 2025 Presentation
• 11.12.2025 - Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
• 11.12.2025 - Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
• 11.10.2025 - Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
• 11.10.2025 - Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSAat the 36th International Symposium on the Autonomic Nervous System
• 11.02.2025 - Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
• 10.31.2025 - Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

Recent Filings

• 11.13.2025 - EX-99.1 EX-99.1
• 11.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.12.2025 - EX-99.1 EX-99.1
• 11.10.2025 - EX-99.1 EX-99.1
• 11.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.31.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.31.2025 - EX-99.1 EX-99.1
• 10.21.2025 - EX-99.1 EX-99.1
• 10.21.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]